Literature DB >> 23250657

Imaging of inflammation and calcification in aortic stenosis.

Marc R Dweck1, Nikhil V Joshi, James H F Rudd, David E Newby.   

Abstract

Aortic stenosis is a common clinical condition that is set to increase in prevalence with an ageing population. However, reliable methods for predicting disease progression and effective medical therapies are lacking. Inflammation and calcification are believed to have a key role but until recently the relative contributions of these processes at the different stages of the disease process were unknown. Recent studies have suggested that combined positron emission tomography and computed tomography (PET/CT) is a feasible and reproducible method for measuring the degree of inflammation and calcification in the valves of patients with aortic stenosis. For the first time this provides us with a potential method of measuring disease activity, which might then allow prediction of progression and act as a surrogate endpoint in studies of novel therapies. In this review, we will examine the basis for PET/CT scanning and discuss the studies that have investigated its use in aortic stenosis. We will cover the work that is still required in order to validate this technique and how it might impact on future clinical research and practice. Finally, we will examine alternative imaging methods that might also provide insight in to the underlying pathogenesis of this important and common clinical condition.

Entities:  

Mesh:

Year:  2013        PMID: 23250657     DOI: 10.1007/s11886-012-0320-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  44 in total

1.  In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: correlation with atherogenic risk factors.

Authors:  Thorsten Derlin; Christian Wisotzki; Ulrich Richter; Ivayla Apostolova; Peter Bannas; Christoph Weber; Janos Mester; Susanne Klutmann
Journal:  J Nucl Med       Date:  2011-02-14       Impact factor: 10.057

2.  Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography increased valvular fluorodeoxyglucose uptake in aortic stenosis.

Authors:  Gergana Marincheva-Savcheva; Sharath Subramanian; Sadia Qadir; Amparo Figueroa; Quynh Truong; Jayanthi Vijayakumar; Thomas J Brady; Udo Hoffmann; Ahmed Tawakol
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

3.  Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.

Authors:  Eduardo J Folco; Yuri Sheikine; Viviane Z Rocha; Thomas Christen; Eugenia Shvartz; Galina K Sukhova; Marcelo F Di Carli; Peter Libby
Journal:  J Am Coll Cardiol       Date:  2011-08-02       Impact factor: 24.094

4.  Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; J Thyberg; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

Review 5.  Calcific aortic stenosis: a disease of the valve and the myocardium.

Authors:  Marc R Dweck; Nicholas A Boon; David E Newby
Journal:  J Am Coll Cardiol       Date:  2012-10-10       Impact factor: 24.094

6.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

Authors:  K D O'Brien; D D Reichenbach; S M Marcovina; J Kuusisto; C E Alpers; C M Otto
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

7.  18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.

Authors:  Axel Rominger; Tobias Saam; Sarah Wolpers; Clemens C Cyran; Michael Schmidt; Stefan Foerster; Konstantin Nikolaou; Maximilian F Reiser; Peter Bartenstein; Marcus Hacker
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

8.  Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Authors:  Kwan Leung Chan; Koon Teo; Jean G Dumesnil; Andy Ni; James Tam
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

9.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

10.  Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events.

Authors:  Benoît Paulmier; Michèle Duet; Raphaël Khayat; Nadia Pierquet-Ghazzar; Jean-Pierre Laissy; Christophe Maunoury; Florent Hugonnet; Elisabeth Sauvaget; Ludovic Trinquart; Marc Faraggi
Journal:  J Nucl Cardiol       Date:  2008 Mar-Apr       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.